EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Psychosocial and NF‐κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART‐3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial

Lucy Finkelstein-Fox iD, John W Denninger, Leah E Walsh iD, Jacob P Laubach, Andrew Jenho Yee, Elizabeth O'Donnell, Eric A Macklin, Xuesong Gu, Alona Muzikansky, Towia A Libermann, Gabriella Nicolosi, Paul G Richardson und 6 weitere

Psycho-Oncology · 2025

DOI: 10.1002/pon.70216 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Lucy Finkelstein-Fox und 17 weiteren Autor:innen. Beteiligte Einrichtung: Health Promotion and Resiliency Intervention Research (HPRIR) Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Stress, Psychological, Multiple Myeloma, NF-kappa B, Monoclonal Gammopathy of Undetermined Significance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Adolph Coors Foundation, NCI NIH HHS, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), precursors to multiple myeloma, need supports for the psychological sequelae of medical uncertainty.

Aims

This secondary and exploratory analysis of psychosocial outcomes from a randomized controlled trial evaluated a mind‐body intervention, the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART‐3RP) for perceived stress, global distress and secondary distress (depression, anxiety, NF‐κB DNA‐binding activity) and well‐being (coping ability, mindfulness, optimism, gratitude) indices for individuals with MGUS and SMM.

Methods

Participants were randomized to immediate treatment ( n = 45) or waitlist control ( n = 48), providing data at baseline (T1), 3 months (T2), and 6 months (T3).

Results

Compared to waitlist control, the immediate treatment group experienced greater T1‐T2 reductions in global distress ( M diff = −1.04, p = 0.04), but not perceived stress ( M diff = −1.67, p = 0.12). Participants receiving immediate treatment also experienced greater reductions in depression ( M diff = −4.22, p < 0.001) and improvements in coping abilities ( M diff = 0.36, p < 0.001) and optimism ( M diff = 1.39, p = 0.02), with no significantly different changes in mindfulness ( M diff = 4.36, p = 0.14), anxiety ( M diff = −1.23, p = 0.26), gratitude ( M diff = 0.59, p = 0.47), or NF‐κB activity ( M diff = −0.16, p = 0.23).

Conclusions

The SMART‐3RP demonstrated efficacy for global distress and other important outcomes for individuals with MGUS and SMM. Stress reduction did not significantly differ from waitlist control. Trial Registration: ClinicalTrials.gov Registration #: NCT01955395

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress, PsychologicalMultiple MyelomaNF-kappa BMonoclonal Gammopathy of Undetermined SignificanceResilience, PsychologicalRelaxation TherapyMind-Body TherapiesHumansFemaleMaleMiddle AgedAgedAdaptation, PsychologicalAnxietyDepressionMindfulnessTreatment Outcome

Stichwörter der Autor:innen

cancermind‐body interventionmonoclonal gammopathy of undetermined significancemultiple myelomaoncologypsychological interventionpsycho‐oncologyresiliencesmoldering multiple myelomastress management

Substanzen

NF-kappa B

Autor:innen und Institutionen

  • Health Promotion and Resiliency Intervention Research (HPRIR) Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Benson Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Brookdale Dept. of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Hematology/Oncology, Dana Farber Cancer Institute, New York, New York, USA.
  • Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.

ORCID-Profile: Lucy Finkelstein-Fox, Leah E Walsh

Förderung

  • Adolph Coors Foundation
  • NCI NIH HHS
  • American Cancer Society
  • Onyx Pharmaceuticals
  • National Cancer Institute

Zitieren

APA

Finkelstein-Fox, L., Denninger, J. W., Walsh, L. E., Laubach, J. P., Yee, A. J., O'Donnell, E., Macklin, E. A., Gu, X., Muzikansky, A., Libermann, T. A., Nicolosi, G., Richardson, P. G., Raje, N. S., Fricchione, G. L., Perez, G. K., Traeger, L. N., Chad-Friedman, E., & Park, E. R. (2025). Psychosocial and NF‐κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART‐3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial. Psycho-Oncology. https://doi.org/10.1002/pon.70216

Vancouver

Finkelstein-Fox L, Denninger JW, Walsh LE, Laubach JP, Yee AJ, O'Donnell E, et al. Psychosocial and NF‐κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART‐3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial. Psycho-Oncology. 2025. doi:10.1002/pon.70216

BibTeX
@article{FinkelsteinFox2025,
  author = {Finkelstein-Fox, Lucy and Denninger, John W and Walsh, Leah E and Laubach, Jacob P and Yee, Andrew Jenho and O'Donnell, Elizabeth and Macklin, Eric A and Gu, Xuesong and Muzikansky, Alona and Libermann, Towia A and Nicolosi, Gabriella and Richardson, Paul G and Raje, Noopur S and Fricchione, Gregory L and Perez, Giselle K and Traeger, Lara N and Chad-Friedman, Emma and Park, Elyse R},
  title = {Psychosocial and NF‐κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART‐3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial},
  journal = {Psycho-Oncology},
  year = {2025},
  doi = {10.1002/pon.70216}
}
Kostenlos starten →